Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0606920210290010001
Biomolecules & Therapeutics
2021 Volume.29 No. 1 p.1 ~ p.10
COVID-19 Vaccine: Critical Questions with Complicated Answers
Haidere Mohammad Faisal

Ratan Zubair Ahmed
Nowroz Senjuti
Zaman Sojib Bin
Jung You-Jung
Hosseinzadeh Hassan
Cho Jae-Youl
Abstract
COVID-19 has caused extensive human casualties with significant economic impacts around the globe, and has imposed new challenges on health systems worldwide. Over the past decade, SARS, Ebola, and Zika also led to significant concerns among the scientific community. Interestingly, the SARS and Zika epidemics ended before vaccine development; however, the scholarly community and the pharmaceutical companies responded very quickly at that time. Similarly, when the genetic sequence of SARSCoV-2 was revealed, global vaccine companies and scientists have stepped forward to develop a vaccine, triggering a race toward vaccine development that the whole world is relying on. Similarly, an effective and safe vaccine could play a pivotal role in eradicating COVID-19. However, few important questions regarding SARS-CoV-2 vaccine development are explored in this review.
KEYWORD
COVID-19, Vaccine, Vaccine backfires, Vaccine safety
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed